Clarithromycin-based Triple Therapy for 14 Days Versus Sequential Therapy 10 Days in the First Line Therapy

计划入组 1,300 人 · 首次发布于 2012 年 5 月 30 日

eOnOff - D1 Extension

计划入组 34 人 · 首次发布于 2017 年 8 月 11 日

A Phase I Study of ZN-d5 in Chinese Subjects With Non-Hodgkin Lymphoma

计划入组 8 人 · 首次发布于 2021 年 11 月 19 日

NNPI-D5

FWJ-D5

ZN-d5

Tavapadon Shows Promise in Phase 3 Trials for Parkinson's Disease with Improved Motor Function and Safety Profile

Annovis Bio's Buntanetap Enters Phase 3 for Early Alzheimer's, AbbVie's Tavapadon Shows Promise in Parkinson's

Tavapadon Shows Promise for Parkinson's Disease Treatment in Phase 3 Trials